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ABSTRACT
Protein synthesis is a fundamental requirement of all
cells for survival and replication. To date, vast num-
bers of genetic and biochemical studies have been
performed to address the mechanisms of translation
and its regulation in Escherichia coli, but only a lim-
ited number of studies have investigated these pro-
cesses in other bacteria, particularly in slow grow-
ing bacteria like Mycobacterium tuberculosis, the
causative agent of human tuberculosis. In this Re-
view, we highlight important differences in the trans-
lational machinery of M. tuberculosis compared with
E. coli, specifically the presence of two additional
proteins and subunit stabilizing elements such as
the B9 bridge. We also consider the role of leaderless
translation in the ability of M. tuberculosis to estab-
lish latent infection and look at the experimental ev-
idence that translational regulatory mechanisms op-
erate in mycobacteria during stress adaptation, par-
ticularly focussing on differences in toxin-antitoxin
systems between E. coli and M. tuberculosis and on
the role of tuneable translational fidelity in conferring
phenotypic antibiotic resistance. Finally, we consider
the implications of these differences in the context of
the biological adaptation of M. tuberculosis and dis-
cuss how these regulatory mechanisms could aid in
the development of novel therapeutics for tuberculo-
sis.
INTRODUCTION
Life processes have historically been considered to be well
conserved amongst all domains of life. However, there is
increasing evidence that even fundamental biological pro-
cesses can differ between organisms. One example is trans-
lation, the process by which the sequence of nucleotides in a
messenger RNA (mRNA) molecule directs the synthesis of
polypeptides. With growing evidence that translational reg-
ulation associated with heterogeneity in ribosomal compo-
sition makes an important contribution to biological adap-
tation (1,2), it is important to better understand the extent
to which selective translation can shape the bacterial pro-
teome, particularly during pathogenesis.
Translation takes place on the ribosome, a ribonucleo-
protein composed of a small and a large subunit. The small,
30S, subunit reads the mRNA whilst the large, 50S, sub-
unit catalyses peptide bond formation between incoming
amino acids and the growing nascent chain. The ribosome
has three binding sites for transfer RNA (tRNA): the A-
(aminoacyl) site, the P- (peptidyl) site and the E- (exit) site,
formed in the inter-subunit interface. Translation is an intri-
cate process that involves many cellular components, with
about half of the energy expenditure of growing cells being
used towards protein synthesis (3).
Mycobacterium tuberculosis is the causative agent of hu-
man tuberculosis (TB), one of humankind’s deadliest dis-
eases. Tuberculosis remains a threat to the health of peo-
ple worldwide. The World Health Organization (WHO) es-
timated 10.4 million new cases of TB and 1.4 million deaths
caused by this disease in 2016 (4). Furthermore, it is esti-
mated that one-quarter of the world’s population harbours
the bacterium in the form of an asymptomatic infection re-
ferred to as latent TB (5). Person-to-person transmission
occurs by inhalation of aerosolized droplets generated by an
individual with active disease. Among infected individuals,
only aminor percentage will develop clinical manifestations
of active TB whilst most will remain latently infected, with
bacteria contained within clusters of immune cells called
granulomas in the lung (Figure 1). The immunology of
TB is complex and multifaceted and even today it is not
well known which immunological parameters or biomark-
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Figure 1. Schematic representation of the life cycle ofM. tuberculosis. Person-to-person transmission occurs by inhalation of aerosolized droplets generated
by a person with active disease. Bacteria travel to the lungs, where they are taken up by alveolar macrophages. Inside the alveolar macrophages bacteria
are exposed to reactive oxygen (ROS) and nitrogen (NOS) species generated by macrophages. M. tuberculosis is able to evade macrophage killing by
inhibiting phagosome-lysosome fusion. This leads to recruitment of immune cells, which contributes to the formation of granulomas which can contain
M. tuberculosis. In 90% of the cases, infected individuals contain the infection within the granuloma, where the bacteria are able to survive in a non-
replicating state, probably triggered by hypoxic and nutrient starved conditions. In around 10% of cases, the disease will progress and develop to active
disease, which can lead to release ofM. tuberculosis from the granulomas. In a small percentage of latently infected individuals, the disease can reactivate
later in life leading to the development of active disease.
ers predict who will control the infection and who will de-
velop clinical disease (6).
Latent infection not only presents an enormous reservoir
of potential reactivation of TB but also reflects the com-
plex life cycle of the bacteria that can involve prolonged
periods of non-replicating persistence (where the host is
able to control the infection but not completely eradicate
the bacteria) (Figure 1) (7). During non-replicating per-
sistence, protein synthesis is globally down-regulated and
bacteria are correspondingly less susceptible to antibiotics
(8). Still today, the mechanisms underlying persistence in
the human host are poorly understood. Adaptive responses
have been extensively analysed by transcriptional profiling
in well-defined experimental models (9–13) and in combi-
nation with ChIP-seq analysis, this information is being
used to construct networks of genes that have the poten-
tial to predict transcriptional responses that occur in en-
vironments encountered during in vivo infection (14–17).
However, the extent to which the transcriptome can be used
to predict changes in the proteome and metabolome––and
ultimately drug susceptibility––remains undetermined. For
example, immediate survival of M. tuberculosis under ni-
tric oxide stress is likely to be driven by selective degrada-
tion of specific proteins and rapid metabolic adjustments
rather than by transcriptional regulation itself (18). The re-
cent identification of an extensive leaderless transcriptome
in M. tuberculosis (19), characterized by genes lacking a
Shine-Dalgarno (SD) sequence, togetherwith the identifica-
tion of novel features in themycobacterial ribosome (20–23)
highlight a potentially important layer of translational reg-
ulation, which could reflect the plasticity of this pathogen
to adapt to diverse environmental conditions. The basic bi-
ology of M. tuberculosis is clearly different to the model
organism Escherichia coli and fundamental biological pro-
cesses in the single bacterial cell should be re-assessed in
light of these differences.
In this review, we summarize what is known about the
translational machinery in mycobacteria, discussing the lat-
est evidence that supports the existence of non-canonical
translation mechanisms that could contribute to the phe-
notypic adaptation of M. tuberculosis. We begin with an
overview of translation, before discussing differences be-
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tween the translational machinery in E. coli and M. tuber-
culosis. We then look at the effects of cellular stress, includ-
ing the production of toxins and exposure to antibiotics on
translation. Finally, we offer perspectives on how a better
understanding of translational regulation could be directly
relevant to the understanding ofM. tuberculosis pathogen-
esis and potentially applied to the rational design of drug
combinations for TB treatment
TRANSLATION INITIATION IN BACTERIA: FROM THE
CANONICAL MECHANISM TO LEADERLESS TRANS-
LATION
Translation occurs in four steps: initiation, elongation, ter-
mination and ribosome recycling. Each of these steps is
highly regulated and subject to control mechanisms that en-
sure the fidelity of the translated product. However, prob-
ably the most stringent regulatory mechanisms operate at
the level of initiation. In bacteria, canonical translation ini-
tiation involves the binding of mRNA, the three initiation
factors (IFs) and the initiator tRNA (N-formylmethionine-
charged tRNA; fMet-tRNAfMet) to the small ribosomal
subunit to form the 30S pre-initiation complex. In prokary-
otes, this involves direct interaction between the transcript
mRNA and the ribosomal RNA (rRNA). The binding gen-
erally occurs between the SD sequence, a purine-rich region
upstream of the start codon of mRNA and the complemen-
tary anti-Shine-Dalgarno (a-SD) sequence on 16S rRNA.
The 30S subunit may bind to any single-stranded region of
the mRNA near the translation start site, unwinding any
secondary structure. A realignment then occurs to position
the start codon in the P-site of the 30S subunit. Next, the
large ribosomal subunit docks onto the preinitiation com-
plex, promoted by IF2, which forces the fMet-tRNAfMet
into the correct orientation at the P-site (24). The efficiency
of docking is dependent on the nature of the mRNA ri-
bosome binding site (RBS) including the sequence of the
start codon, any mRNA secondary structure present, the
presence of an SD sequence and AU-rich elements in the
mRNA. The strength of the RBS is a reasonably good pre-
dictor of translation efficiency (25). Lastly, the three IFs dis-
sociate, catalysed by GTP hydrolysis by IF2, and the result-
ing 70S complex is committed for translation (Figure 2A).
The interaction between the SD and the a-SD motifs is
thought to be the canonical mechanism for translation initi-
ation in bacteria, as alterations of the SD sequence strongly
inhibit protein synthesis (26–28). However, representation
of genes with SD motifs in their leader sequence is highly
variable across bacterial genomes (29) and genes lacking
a leader sequence (known as leaderless) are widespread
among bacteria (30).
At least two alternative mechanisms of translation initi-
ation have been described to operate in bacteria. The first
is mediated by the ribosomal protein bS1, a component of
the 30S subunit. In E. coli, bS1 can directly interact with
AU-rich sequences upstream of the SD sequence in the
mRNA resulting in efficient initiation of translation (31,32)
(Figure 2B). There is no similar protein to the ribosomal
protein bS1 in Eukaryotes, but it is well conserved among
Gram-negative bacteria, with six distinct domains present
that play defined roles during the translation process in E.
coli. More distantly related forms have been described in
Gram-positive bacteria that vary in the presence and con-
servation of the protein domains. Interestingly, members of
the phylum Actinobacteria, which includesM. tuberculosis,
have a bS1 that has an uncharacterized C-terminal domain
that could influence the specificity of bS1-mediated initia-
tion (33).
The second mechanism operates when mRNAs lack the
5′ elements usually required by the ribosome for binding.
Such mRNAs are described as leaderless and without the
presence of a 5′ untranslated region (UTR) or ribosome
recognition signals, they are thought to represent an early
evolutionary relic of translation (34). Despite their sus-
pected ancestral origin, leaderless mRNAs are found in all
domains of life (30).
In bacteria initiation of translation of leaderless mRNAs
occurs by amechanism involving pre-formed 70S ribosomes
(35) (Figure 2C). It has been shown that in E. coli lead-
erless translation requires a 70S ribosome and an mRNA
transcript equipped with a 5′ terminal phosphate (36,37).
In fact, in the presence of an initiator tRNA, 70S ribosomes
have a ∼10-fold higher affinity for 5′ AUGs than 30S sub-
units have (35 and references therein). In E. coli, initiation
by 70S ribosomes also requires an AUG start codon situ-
ated in close proximity to the 5′ terminus (38); alteration
of the AUG start codon to other naturally occurring initi-
ation codons is insufficient for the translation of leaderless
mRNA (39). Initiation then proceeds via binding of the ini-
tiator fMet-tRNAfMet to the 70S ribosome followed by the
leaderless mRNA binding. The ratio of IF2 and IF3 plays
a decisive role in the initiation of leaderless mRNAs, with
higher relative concentrations of IF2 promoting leaderless
translation (40).
The distribution of leaderless transcripts has been pre-
dicted to be diverse amongst Eubacteria, with a notably
high representation amongst the Actinobacteria (41,42).
Few leaderless mRNAs are expressed in E. coli during op-
timal growth, and 70S-initiation yields less efficient trans-
lation than canonical SD-mediated initiation. Thanks to
advances in next-generation sequencing technologies, map-
ping of transcriptional start sites (TSSs) at a genome-wide
level is now possible, revealing the primary transcriptome
of bacterial pathogens (43). This technique has allowed the
quantification of leaderless transcripts at a transcriptome-
wide level, confirming their high abundance amongst mem-
bers of the Actinobacteria (44,45). In particular, genome-
wide mapping of TSSs in M. tuberculosis has revealed that
approximately a quarter of the transcriptome is expressed
as leaderless (19,46), highlighting a fundamental differ-
ence with the transcriptome of other bacterial pathogens
where only one to two percent of the transcriptome is lead-
erless (43,47,48). Interestingly, the contribution of lead-
erless translation to the shaping of the E. coli proteome
varies when environmental conditions change, and bacte-
ria face different stresses, highlighting the potential impli-
cation of this alternative translation initiation mechanism
in re-shaping the bacterial proteome during stress adapta-
tion.
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Figure 2. Mechanisms of translation initiation in bacteria. (A) Mechanism of canonical SD initiation involving recruitment of the 30S subunit through
the SD - a-SD interaction. Formation of the 30S pre-initiation complex occurs by binding of IFs1–3 and the initiator tRNA, fMet-tRNAfMet, to the 30S
subunit of the ribosome. The SD sequence (represented in blue) is then selected and binds the a-SD sequence (represented in orange) in the 16S rRNA.
Recognition of the AUG start codon triggers the stabilisation of fMet-tRNAfMet binding. The 50S subunit docks on the pre-initiation complex and GTP
hydrolysis by IF2 results in dissociation of the IFs and tightening of the 70S complex ready for translation. (B) Mechanism of initiation involving the
interaction between ribosomal protein bS1 and AU rich elements in the mRNA. This mechanism operates when either a weak SD sequence is present, or
it is totally absent. Formation of the 30S pre-initiation complex is mediated by direct interaction of ribosomal protein bS1 with AU-rich elements situated
upstream from the SD sequence. (C) Mechanism of initiation of leaderless translation. IF2 and the initiator tRNA bind independently to the 70S ribosome,
leaderless mRNA is recruited through recognition of its 5′ phosphate group and AUG start codon. Following GTP hydrolysis by IF2, the IF dissociates,
and the complex is committed for translation.
PREFERENTIAL TRANSLATION OF LEADERLESS
mRNAS IN E. coli
In E. coli, efficient translation of leaderless transcripts is
performed by specialized ribosomes. The concept of special-
ized ribosomes emerged after the identification of hetero-
geneity in the composition of ribosomes amongst a broad
range of organisms and cell types (reviewed in (1)). This het-
erogeneity can result from differential expression or post-
translational modifications of ribosomal proteins, differ-
ences in the rRNA sequence or variation in the activity of
ribosome associated factors.
There are two mechanisms described in E. coli that gen-
erate specialized ribosomes that either lack specific riboso-
mal proteins or have structural changes in the 16S rRNA.
Both mechanisms are triggered by stress conditions such as
the presence of antibiotics or bacterial toxins (49,50). The
first mechanism can be induced following exposure to ka-
sugamycin, an aminoglycoside antibiotic that inhibits for-
mation of the initiation complex by binding to the 30S sub-
unit and inducing dissociation of the P-site-bound fMet-
tRNAfMet through perturbation of the mRNA. This results
in inhibition of the translation of SD but not leaderless
transcripts (51,52). In addition to changes induced by di-
rect binding to the ribosome, kasugamycin also induces the
formation of 61S ribosomes in E. coli, both in vitro and in
vivo. These specialized ribosomes are devoid of several small
subunit proteins, including bS1 and bS21, have structural
changes in the 16S rRNA (in particular within helix 45 at
the 3′-terminus) and are proficient in selectively translating
leaderless mRNAs (49).
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The second mechanism is mediated by the MazF toxin.
MazEF is a stress-induced toxin-antitoxin (TA) module im-
plicated in stress survival and persistence (53). Under op-
timal growth conditions, the toxin, MazF, is neutralized
by binding to the antitoxin, MazE. However, under stress
conditions, the unstable antitoxin is degraded and, MazF
inhibits translation by cleaving both mRNA and rRNA.
In E. coli, Vesper and colleagues have shown that MazF
cleaves at ACA sequences within the 5′UTR of mRNAs,
removing the SD sequences and hence generating leader-
less transcripts (50). The system also targets 16S rRNA,
cleaving off the 3′-terminal 43 nucleotides of the 16S rRNA
that include the a-SD sequence and resulting in the forma-
tion of 70S43 stress-ribosomes that selectively translate the
newly cleaved leaderless mRNAs. Further studies combin-
ing RNA sequencing with polysome profiling have identi-
fied a MazF regulon comprising over 300 genes in the E.
coli transcriptome that are selectively targeted (54). Inter-
estingly, the set ofMazF-processed transcripts identified en-
code proteins with a broad variety of functions, leading the
authors to conclude that translational reprogramming in E.
coli serves as a fast and effective mechanism for shaping the
proteome during stress to guarantee bacterial survival. Fur-
thermore, it has been recently shown that the 70S43 stress-
ribosomes generated as a result of the post-transcriptional
response generated by MazF can be repaired when optimal
growth conditions resume (55). During stress conditions,
both the 70S43 ribosome and the cleaved RNA43 are sta-
ble, but upon recovery from stress the stable RNA43 can
be re-ligated to the 16S43 rRNA via the RNA ligase RtcB,
generating repaired 70S ribosomes that are able to trans-
late canonical mRNAs. This reversibility of ribosome het-
erogeneity opens a new layer on the control of translational
regulation in bacteria, equipping the bacterial cell with a
dynamic mechanism to modulate the proteome in response
to varying conditions.
As previously mentioned, M. tuberculosis has an ex-
tensive leaderless transcriptome (19,46). In M. tuberculo-
sis, leaderless genes are not evenly distributed throughout
the transcriptome, but genes encoding proteins with sec-
ondary adaptive functions, such as TA systems, are over-
represented amongst leaderless mRNAs (19). Using trans-
lational reporters, Shell and colleagues were able to demon-
strate that leaderless translation in Mycobacterium smeg-
matis, a non-pathogenic and fast-growingmycobacteria fre-
quently used as a surrogate model for M. tuberculosis, can
be efficient when either an AUG or GUG codon is present
at the 5′end of the mRNA (46), revealing an important dif-
ference from the E. coli model, in which an AUG codon is
strongly preferred (56). Furthermore, the observation that
under conditions of nutrient starvation, the abundance of
leaderless transcripts increases (19) highlights a potential
target for translational regulation in M. tuberculosis. It is
not yet known whether a similar specialized subpopula-
tion of ribosomes as that described in E. coli, is responsible
for leaderless translation in mycobacteria, or whether my-
cobacterial ribosomes are more versatile and the same pop-
ulation can translate either canonical leadered or leaderless
mRNAs. Taken together with the observations that kasug-
amycin treatment and the presence of endogenous toxins
also influence not only the translatome but also the trans-
lational machinery of the cell, this suggests that leaderless
translation may be an important aspect of the adaptive re-
sponse of bacteria (19,46). During the next sections, we will
review evidence that could support this hypothesis.
RIBOSOMAL HETEROGENEITY IN MYCOBACTERIA:
INSIGHTS FROM STRUCTURAL STUDIES
It is anticipated that structural studies of ribosomes from
M. tuberculosis may help to shed light on the mechanism
of leaderless translation in mycobacteria, specifically on
whether all ribosomes are equally capable of translating all
types of transcript, or whether a specialized subpopulation
of ribosomes preferentially translates leaderless mRNAs.
Prokaryotic ribosomes, exemplified by the model organ-
ism E. coli, are around 20 nm in diameter with a molecular
weight of∼2.5 MDa and comprise two subunits. In E. coli,
the 30S subunit consists of 16S rRNA (1542 nucleotides)
and 21 proteins (S1–S21). The large subunit consists of 5S
rRNA (120 nucleotides), 23S rRNA (2904 nucleotides) and
33 proteins (L1-L36, where the previously annotated bL12
has been shown to be a complex of bL7/bL12, L8 to be
absent and L26 to be bS20). With the exception of bS21,
which is implicated in SD-mediated initiation (57), all E.
coli ribosomal proteins have homologues in M. tuberculo-
sis, although there are some differences in size and charge.
In general, ribosomal proteins from M. tuberculosis are
larger than those from E. coli, with some (uS2, uS3, uS5,
uS9, bS16, uS17, bS18, uL4, uL10, bL17, uL22, bL25 and
uL29) thirteen or more residues longer than theirE. coli ho-
mologues. The larger size of M. tuberculosis proteins com-
pared with E. coli proteins is in good agreement with data
from M. smegmatis, in which the same proteins are also
larger than their E. coli homologues (20). Furthermore, ri-
bosomal proteins fromM. tuberculosis also tend to be more
positively charged (have a higher isoelectric point) than
those from E. coli, especially bS6, bL9 and uL22. The ab-
sence of bS21 in M. tuberculosis is interesting because it
represents a point of similarity between mycobacterial ri-
bosomes and 61S ribosomes from E. coli that are both able
to translate leaderless transcripts with high efficiency (49).
In addition, the ribosomal protein bS1 differs between ri-
bosomes from E. coli and M. tuberculosis. In E. coli, bS1
comprises six domains; domains 1 and 2 bind the protein
to the ribosome, whilst domains 3–6 are involved in inter-
actions with the mRNA, including mediating mRNA un-
folding and docking (58) with the sixth domain having been
shown to be dispensable for translation initiation. InM. tu-
berculosis, the sixth domain of bS1 is replaced by a domain
of unknown function of approximately 100 residues, which
seems to be specific toActinobacteria and renders bS1 func-
tionally inequivalent to bS1 from E. coli (33). In addition
to the set of ribosomal proteins required for assembly of
the bacterial ribosome,M. tuberculosis has at least four du-
plicated or alternative ribosomal proteins, that differ from
their primary partner in lacking aCys-rich zinc bindingmo-
tif. Interestingly, the ratio of primary to alternative ribo-
somal protein bS18 in M. tuberculosis varies during con-
ditions of zinc deprivation, with an increased production
of the alternative protein that gets assembled into alterna-
tive ribosomes. This mechanism might provide the bacteria
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky574/5045644
by London School of Hygiene & Tropical Medicine user
on 05 July 2018
6 Nucleic Acids Research, 2018
with a mechanism to ensure protein production in the zinc
depleted extracellular environment, following release from
macrophages (59,60).
The near-atomic resolution structures of ribosomes from
M. smegmatis andM. tuberculosis were published recently,
yielding important insights into the translational machin-
ery of this pathogen (21,23). Compared with other bacterial
ribosomes, the overall architecture of M. tuberculosis ribo-
somes is conserved, with all the usual structural landmarks
(the central protuberance, the L1 stalk etc.) in place. How-
ever, some regions of additional electron densitywere noted,
which correspond to structures that appear to be unique to
mycobacterial ribosomes.
Most notably, two new protein densities were discovered
near the decoding centre and the peptidyl transferase cen-
tre (PTC) (Figure 3A). The first of these proteins, desig-
nated bL37, sits close to the PTC and appears to be unique
to mycobacteria. It consists of ∼20 residues and adopts an
alpha-helix-coiled loop structure. The protein resides in a
pocket formed by helices H39 and H89 of the 23S rRNA
(Figure 3B). The presence of this protein is corroborated by
evidence from the structure of the ribosome fromM. smeg-
matis, in which a similar pattern of electron density was ob-
served (20,21). The second protein, named bS22, closely re-
sembles the eukaryotic protein eL41, in terms of both fold
and location. The protein lies in a highly conserved pocket
that is found empty in E. coli (61) (Figure 3C) but occupied
by an alpha-helical protein in both cytosolic and mitochon-
drial ribosomes from Saccharomyces cerevisiae and Homo
sapiens (62–65). This protein is also present in theM. smeg-
matis ribosome where it is hypothesized to play a major role
in the stabilization of the assembled 70S complex (21).
Other interesting features of M. tuberculosis ribosomes
were also uncovered, including the presence of a novel inter-
subunit bridge, B9, present in about 80% of the ribosomes,
formed from a 100-nucleotide expansion in the 23S rRNA,
that undergoes a dramatic conformational change upon as-
sociation of the 30S and 50S subunits (Figure 3E and F).
The authors propose that this structure may play a role in
coordinating translation initiation in M. tuberculosis, per-
haps by preventing the premature formation of the 70S ri-
bosome until the initiation complex is properly formed. In-
triguingly, the study also found that M. tuberculosis ribo-
somes exhibit significant structural heterogeneity, raising
the possibility that there may be subpopulations of ribo-
somes that differ from canonical ribosomes––perhaps these
specialized ribosomes are responsible for the translation of
leaderless mRNAs inM. tuberculosis. For example, the ab-
sence of the B9 bridge in 20% of the ribosomes could render
these ribosomesmore amenable to 70S association, which is
a prerequisite for the translation of leaderless mRNAs (Fig-
ure 3G).
Ribosomal heterogeneity can also be achieved at the level
of the stabilized ribosome. Ribosome stabilization can be
defined as the association of ribosomal subunits or ribo-
somes rendering the ribosome translationally inactive. In
E. coli, when cells stop growing a proportion of the ribo-
somal population undergoes dimerization, generating 100S
ribosomal dimers that are translationally inactive and con-
sidered to be in a hibernation state (reviewed in (66)) (Fig-
ure 4A). This provides another example for reversible bac-
terial stress management, so when cellular conditions be-
come favourable again the hibernating ribosomes can be
disassembled and recycled for new rounds of translation.
In contrast to E. coli, it has been shown that under con-
ditions of hypoxic stress, M. tuberculosis ribosomes do not
form 100S dimers but become stabilized in the associated
70S form and do not readily dissociate into their 30S and
50S subunits (67). This stabilization is mediated by the pro-
tein RafH, a member of the DosR regulon (67). The DosR
regulon comprises over 50 genes and is involved in induc-
ing dormancy inM. tuberculosis (68). InM. smegmatis, the
RafH protein becomes associated with the ribosome under
hypoxic conditions (67) (Figure 4A). This is one of the two
long hibernation promoting factors (HPF) described inM.
tuberculosis that are related to the RMF/short-HPF/YfiA
proteins of E. coli (69) and bind to ribosomes in a way that
modifies subunit interactions and translational efficiency. In
addition, a recent study has identified structural similarities
for the geneRv1738 toHPFs fromE. coli using racemic pro-
tein crystallography (70). This gene is highly up-regulated in
M. tuberculosis during conditions thought to trigger the on-
set of dormancy, like hypoxia and exposure to nitric oxide
(68,71), providing a new ribosome-associated protein that
could selectively modify the proteome by interacting with
ribosomes. Ribosome silencing factors also bind to the ribo-
some under unfavourable growth conditions to shut down
translation. Combining structural studies and biochemical
analysis, Li et al. have shown that during periods of nutri-
ent limitation the ribosomal silencing factor RsfS fromM.
tuberculosis binds to the 50S inhibiting the association of
the small 30S subunit to block protein synthesis (72) (Fig-
ure 4A). RsfS interaction does not affect pre-formed 70S
monosomes, potentially unaltering translation of leaderless
transcripts during nutrient starving conditions.
Altogether, this detailed structural information is prov-
ing a valuable resource for understanding the different lev-
els at which translational regulation can occur and also the
modes of action of numerous antibiotics that target the ri-
bosome. In particular, it may help shed light on the mech-
anisms by which M. tuberculosis becomes resistant to an-
tibiotics and aid in the design of novel compounds to in-
hibit translation. For example, the newly identified protein
bL37 has the potential to influence the orientation of the
23S rRNA close to the linezolid binding site, an oxazolidi-
none antibiotic used to treat M. tuberculosis that is resis-
tant to first-line antibiotics, altering the conformation of nu-
cleotides involved in conferring resistance to this antibiotic
(21). A further species-specific alteration in the rRNA in the
region of the PTC causes remodeling of a tRNA-binding
loop and leads to greater flexibility of the 23S rRNA near
the PTC, with implications for tolerance of mutations that
are lethal in E. coli but confer linezolid resistance in my-
cobacteria (21).
EXPERIMENTAL EVIDENCE FOR TRANSLATIONAL
REGULATION IN MYCOBACTERIA DURING STRESS
ADAPTATION
Having looked at differences in initiation, in the types of
mRNA transcripts that can be decoded and in the structures
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Figure 3. Structural differences in mycobacterial ribosomes. (A) Structure of M. tuberculosis ribosome showing the two novel proteins bL37 (pink) and
bS22 (green). Images generated from alignment of PDB files 5V93 (M. tuberculosis 70S ribosome) and 5O61 (M. smegmatis 70S ribosome; to show bL37).
Zoomed in views of bL37 (B) and bS22 (C). (D) Structure of E. coli ribosome lacking bL37 and bS22 (generated from PDB file 4V4A). (E) The intersubunit
bridge, B9, formed between protein bS6 (orange) and nucleotides 1576–1578 and 1628–1630 of the handle (purple) is present in about 80%ofM. tuberculosis
ribosomes. A zoomed in view of this region is shown in (F). (G) 20% of ribosomes lack the B9 bridge, with implications for subunit assembly.
of ribosomes fromM. tuberculosis andE. coli, in this section
we now consider features of elongation and stress responses.
Codon preference and mistranslation
M. tuberculosis has a GC-rich genome (65%) and this is re-
flected in a strong bias towards G/C at the third base posi-
tion of preferred codons for every amino acid (73). In con-
trast, the preference for G-starting codons appears to be a
general feature of bacteria, regardless of their overall GC
content (74). Preferred codons are those that are recognized
by the most abundant tRNAs and tend to occur in highly
expressed genes, whereas in genes expressed at lower levels,
codon usage is more uniform. Codon usage also has impli-
cations for mRNA stability, with mRNAs rich in optimal
codons being more stable than those rich in rare codons
(75).
Like the ribosome, tRNA is not a passive player in trans-
lation, but rather its role as an adapter molecule between
mRNA and proteins is central to the process. tRNAs have
highly conserved secondary and tertiary structures, cru-
cial for their interactions with proteins and other RNA
molecules but must also possess a certain degree of flexi-
bility. However, misreading can occur. A study inM. smeg-
matis quantified all possible misreading errors at a defined
location in a firefly luciferase reporter protein and found
that during stationary phase there was a significant in-
crease in mistranslation by tRNALys(CCU) from 0.05% mis-
incorporation in exponential growth to 0.2% in stationary
phase. Furthermore, treatment with streptomycin increased
misreading errors at several codons whereas oxidative stress
had no effect on translational fidelity (76). Despite the in-
trinsic need for high translational fidelity, quality control
appears to vary depending on changes in growth conditions.
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Figure 4. Mechanisms by which translational regulation can act in my-
cobacteria. (A) Stabilization of ribosomes during non-optimal growth.
During non-optical growth conditions, both E. coli and Staphylococcus
aureus 70S monosomes form dimers to generate 100S hibernating ribo-
somes through the interaction of their 30S subunits. This hibernation is re-
versible when conditions turn favourable again. Here the 100S hibernating
ribosome from S. aureus is shown (PDB 6FXC) that slightly differs from
the E. coli counterpart (98). In mycobacteria, under hypoxic stress, RafH
promotes the stabilization of 70S ribosomes, whereas under conditions of
starvation, 50S ribosomal subunits are bound by the ribosome silencing
factor, RsfS - crystal structure shown here (PBD 4WCW) - blocking as-
sociation of monomer via interaction with the ribosomal protein uL14.
RsfS interaction does not affect pre-formed 70Smonosomes. (B) Impact of
tRNAmodifications on translation. Top boxes show a schematic of the im-
pact that tRNAmodifications have on translation. Bottom boxes illustrate
the example of uridine 5-oxyacetic acid modification in tRNAThr(UGU) in-
duced by hypoxia in M. bovis. (C) Role of TA systems in M. tuberculosis
translation. MazF-mt3 (PDB 5HK0) cleaves around 20% of M. tubercu-
losis mRNAs and also cleaves within the anti-Shine-Dalgarno (aSD) se-
quence at the 3′ end of 16S rRNA and U*CCUU in 23S rRNA (in the
A-site). MazF-mt3 may possess dual functionality, with the potential to
either completely inactivate the ribosome via 23S rRNA cleavage or alter
the specificity of the ribosome by removing the aSD sequence. MazF-mt6
(PDB 5UCT) cleaves UU*CCU and inactivates the ribosome by cleaving
helix/loop 70 in 23S rRNA in the same position as mt3. MazF-mt9 (PDB
5WYG) is the only MazF member to specifically degrade tRNA inM. tu-
berculosis. The consensus UUU triplet needs to be situated in the middle
of the 7-nt anticodon loop (flanked by 2 nucleotides at either side).
It is possible that mistranslation can even be beneficial to
cells, increasing proteomic diversity and facilitating adap-
tive protein evolution (77). In fact, high rates of substitution
of glutamate for glutamine and aspartate for asparagine
during specific growth conditions, have been shown to lead
to phenotypic resistance to rifampicin inM. smegmatis (78)
and in M. tuberculosis the GatCAB complex mediates the
translational fidelity of glutamine and asparagine codons,
also with implications for rifampicin-specific phenotypic re-
sistance (79).
Amongst all RNA species, tRNAs have the highest
density of post-transcriptional modifications, reviewed in
Lorenz et al. (80). These modifications are important for
the fine-tuning of the 3D structure of tRNA and range
from simple methylations of the base or the ribose to large-
scale hypermodifications that result in significant structural
changes or stabilization. tRNA modifications form a dy-
namic system that can respond to cellular stress by expand-
ing or limiting the decoding capabilities of tRNAs, lead-
ing to the selective up- or downregulation of codon-biased
genes (81) (Figure 4B). This has recently been shown in a
model of hypoxic stress that mimics the environment M.
tuberculosis encounters in granulomas. Chionh et al. grew
cultures of the M. tuberculosis surrogate, M. bovis Bacille
Calmette Gue´rin (BCG), and subjected them to the slow
withdrawal of oxygen before extracting total RNA and an-
alyzing the tRNAs formodifications. They identified a num-
ber of hypoxia-induced tRNAmodifications, some of which
were accompanied by significant changes in the number of
copies of particular tRNAs, leading to up- or downregula-
tion of translation of mRNAs with biased cognate codons
for these tRNAs (Figure 4B). Furthermore, they found that
the BCGgenome exhibits biased use of synonymous codons
that are read by hypoxia-induced reprogrammed tRNAs,
leading to selective translation of proteins from these genes
during hypoxic stress and that the concentration of the
DosR protein, a transcription factor that mediates the hy-
poxic response, was closely paralleled by changes in the level
of tRNAThr(cmo5UGU) but not in the levels of dosR mRNA
(82).
Taken together, a complex picture of codonmatching and
preference begins to emerge in which the stability of the
mRNA, the efficiency of its translation and the modifica-
tion of tRNAs all play a role in determining the amount of
protein produced.
Toxin-antitoxin systems
Toxin-antitoxin (TA) systems are small genetic modules en-
coding both a toxin and its corresponding antitoxin and are
best characterized in E. coli. The antitoxin tends to be less
stable than the toxin and is readily degraded under condi-
tions of environmental stress, freeing the toxin, which then
targets cellular processes such as DNA replication, cell wall
biosynthesis or translation. If further antitoxins are pro-
duced, they will bind to the toxins preventing them from
causing further disruption. Thus activation of TA systems
could facilitate bacterial survival until the environmental
stress is removed and conditions become favourable for
growth again (83). There are five types of TA system catego-
rized by the mode of action of the toxin. Here, we focus on
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type II systems (in which both toxin and antitoxin are pro-
teins) affecting translation. There are differences not only in
the numbers of TA systems in E. coli and M. tuberculosis,
but also in their modes of action and effects on translation.
E. coli has eleven type II TA loci, all of which encode
mRNA endoribonucleases that inhibit global cellular pro-
tein synthesis, inducing persistence.M. tuberculosis has un-
dergone a large expansion in the number of TA systems (79
putative or confirmed) (84), which belong to six families:
VapBC, MazEF, YefM/YoeB, RelBE, HigBA and ParDE.
It has been proposed that active toxins may play a role in
persistence as at least ten TA systems have been shown to
be up-regulated under conditions of antibiotic-induced per-
sistence (85) and conditions that result in arrest of transla-
tion (86). With the exception of the ParDE family, which
blocks DNA replication by inhibiting DNA gyrase, and the
DarTG system that modifies thymidines on single-stranded
DNA by ADP-ribosylation (87), the other toxin families all
act on RNA and influence protein synthesis. In the VapBC
system, the toxin, VapC, is a ribonuclease that cleaves CG-
rich RNAs. There are 50 VapBC systems inM. tuberculosis
and 11 of these have been implicated in persistence due to
their elevated concentrations in a nutrient starvation model
(88). Recently, the cellular targets of these toxins have been
identified in M. tuberculosis (89). These toxins inhibit pro-
tein translation by cleaving RNAs that are essential for de-
coding at the ribosomal A-site. In particular, at least six
VapCs cleave specific tRNAs and the VapC20 toxin cleaves
the conserved Sarcin-Ricin loop of the 23S rRNA (89).
As described above, the MazF toxin from E. coli plays an
important role in the translational reprogramming of the
cell following stress (50,54). M. tuberculosis produces nine
MazF family members TA modules. The toxin MazF-mt6
has been shown to disrupt protein synthesis by cleaving 23S
rRNA in free 50S subunits at a conserved site in the riboso-
mal active centre, the helix/loop 70, disrupting tRNA bind-
ing at the A-site (90,91) (Figure 4C). This cleavage is suffi-
cient to inhibit protein synthesis in the absence of mRNA
cleavage. Furthermore, MazF-mt6 destabilizes the associa-
tion of the 30S and 50S ribosomal subunits (90). In addition
to this role and in similarity with the mechanism described
in E. coli, the toxin MazF-mt3 of M. tuberculosis also has
the ability to cleave the a-SD sequence of 16S rRNA, both
from the precursor andmature forms of 16S rRNAand also
within the context of the 70S ribosome (92) (Figure 4C).
Based on the recognition sequence for cleavage, it is pre-
dicted that only around 20% of M. tuberculosis genes are
susceptible to cleavage by MazF-mt3. Due to the high pro-
portion of leaderless transcripts already present in the M.
tuberculosis genome, it is tempting to speculate that specific
cleavage of mRNAs to create de novo leaderless transcripts
is not as important in this pathogen as it is in E. coli but
that cleavage of the a-SD sequence from the 16S rRNA is
a high priority to ensure the availability of a pool of ribo-
somes capable of translating leaderless transcripts. Finally,
a recent study has shown that in addition to cleavage by
MazF within rRNA and mRNAs, the MazF-mt9 system
from M. tuberculosis preferentially targets a subset of tR-
NAs,mainly tRNAPro14 and tRNALys43 but also tRNALys19,
tRNAVal22, tRNALeu13 and tRNAAsn36 (93) (Figure 4C).
Following a computational analysis to identify proteins en-
riched in proline, lysine and asparagine codons they predict
that the MazF-mt9 system can inhibit or reduce the rate
of protein synthesis for transcripts enriched in these three
amino acids, mainly ribosomal proteins andmembers of the
PE/PPE families, a group of proteins only found in M. tu-
berculosis that have been suggested to be a source of anti-
genic and genetic variation (94).
Both YoeB and RelE toxins from E. coli are ribosome-
dependent ribonucleases that cleave mRNA at the A-site,
albeit by different mechanisms. This feature of RelE has re-
cently been exploited to improve the resolution of ribosome
profiling studies in E. coli (95). M. tuberculosis encodes
two RelBE systems and one YefM/YoeB system and their
overexpression leads to an increase in the proportion of
bacilli surviving rifampicin treatment (96). The HigB toxin
is also a ribosome-dependent ribonuclease that binds the
50S subunit and cleaves AAA sequences on the mRNAs be-
ing translated.M. tuberculosis possesses three HigBA toxin
systems, with HigBA1 and HigBA2 amongst the ten most
up-regulated toxin-antitoxin systems in drug-tolerant per-
sisters (85). The HigBA1 system has been shown to cleave
and degrade transfer-messenger RNA (tmRNA), the stable
RNA product of the ssrA gene, inM. tuberculosis (97).
TA systems thus play a vital role in inducing down- or
selective-regulation of cellular processes, including transla-
tion, in response to environmental cues. As we have seen,
emerging evidence implicates TA systems in inducing per-
sistence, surviving antibiotic treatment and promoting bac-
terial survival until environmental conditions improve. As
such, TA systems are potential targets for therapeutic inter-
ventions against bacterial infection.
PERSPECTIVES
M. tuberculosis responds to environmental change by alter-
ing the expression of critical genes that favour its growth
and survival. As demonstrated in this Review, these changes
operate not only at the level of transcription, but also at the
level of translation, with certain types of transcript chang-
ing in abundance and presumably also in translational effi-
ciency as the ribosome also undergoes changes that favour
particular mechanisms of translation, such as stabilization
of 70S ribosomes.
Both the improvement of new drug treatment regimens
and the development of new therapeutics against TB are
current imperatives, but progress is hampered by our in-
complete understanding of the fundamental biology of the
pathogen and an over-dependence on the knowledge of
E. coli. In particular, the molecular mechanisms underly-
ing the regulation of translation, which ultimately lead to
changes in the metabolic profile of the bacterium, require
clarification. The complex lifestyle of this bacterium renders
M. tuberculosis populations phenotypically heterogeneous,
suggesting a connection between differences in the pheno-
typic state of bacteria and selective mechanisms of trans-
lation. Thus, a deeper understanding of the translational
responses of M. tuberculosis should provide clues to better
understand the adaptive response and identify therapeutic
targets that are susceptible even in persisting bacteria.
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CONCLUSIONS
As we have seen in this Review, there is considerable scope
for diversity of fine mechanistic detail and regulation in life
processes. Translation is a highly conserved process that is
fundamental to life, yet seemingly, small variations in this
process even between bacteria can lead to important differ-
ences in the way bacteria are able to adapt and survive, par-
ticularly in the face of environmental stress. In this Review,
we have considered differences in protein synthesis in the
model organism E. coli and the pathogen M. tuberculosis,
with an emphasis on the role and mechanism of leaderless
translation. We have examined differences in the structure
and composition of the ribosomes from these organisms
and discussed how differences in codon preference and the
toxin-antitoxin systems present influence the translational
landscape of the cell under both optimal and stress condi-
tions.
With the ribosome the target of many antibiotics and an-
tibiotic resistance on the rise, this is an important time to
consider how differences in the translational machinery in
E. coli andM. tuberculosismay have significant implications
for treatment of TB, particularly latent TB infection.
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